A novel role for ATR/Rad3 in G1 phase.

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• Checkpoint kinases, like ATR, are crucial for DNA damage response and genome stability.
• ATR (Ataxia Telangiectasia and Rad3-related) is vital for regulating DNA replication and responding to replication stress.
• ATR inhibitors are under investigation for cancer therapy, necessitating a detailed understanding of ATR functions.

Purpose of the Study:

• To investigate the role of ATR in the G1 phase of the cell cycle.
• To determine the consequences of ATR inhibition during G1 on cell cycle progression and DNA damage.
• To evaluate the impact of ATR inhibition in G1 on long-term cell survival and compare it to inhibition during S phase.

Main Methods:

• Utilized fission yeast (Rad3) and human cell models.
• Administered ATR inhibitors to cells in specific cell cycle phases (G1 and S).
• Assessed cell cycle progression, DNA damage levels, and clonogenic survival rates.

Main Results:

• ATR regulates events in G1 phase during an unperturbed cell cycle.
• ATR inhibition in G1 leads to premature entry into S phase and increased DNA damage.
• ATR inhibition specifically in G1 significantly reduces clonogenic survival.
• Combined ATR inhibition in G1 and S phases results in additive survival reduction, suggesting distinct phase-specific functions.

Conclusions:

• ATR plays a critical role in G1 phase regulation beyond its known roles in S phase and DNA damage response.
• Premature cell cycle progression due to G1 ATR inhibition has deleterious long-term effects on cell survival.
• The distinct effects of ATR inhibition in G1 versus S phase suggest targeting different ATR functions.
• Consideration of ATR inhibitor effects during G1 is essential for optimizing cancer treatment protocols.